A controlled trial antilymphocyte globulin therapy (ALG) in man.
D000818:Animals; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D006041:Goats / Q000276:immunology; D006084:Graft Rejection / Q000532:radiotherapy; D006493:Heparin / Q000627:therapeutic use; D006648:Histocompatibility; D006736:Horses / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive / Q000592:standards*; D007239:Infections; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000209:etiology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003609:Dactinomycin; D006493:Heparin; D001379:Azathioprine; D011241:Prednisone